Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,000,000
-
Number of holders
-
227
-
Total 13F shares, excl. options
-
56,241,583
-
Shares change
-
+1,760,606
-
Total reported value, excl. options
-
$4,386,082,844
-
Value change
-
+$150,414,585
-
Put/Call ratio
-
142%
-
Number of buys
-
132
-
Number of sells
-
85
-
Price
-
$78.00
Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q2 2020
As of 30 Jun 2020 Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) had 279 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 56,241,583 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, VIKING GLOBAL INVESTORS LP, Casdin Capital, LLC, HILLHOUSE CAPITAL ADVISORS, LTD., WELLINGTON MANAGEMENT GROUP LLP, and Invesco Ltd..
This table shows 279 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.